Into the twilight zone - should ER-low breast cancer be treated as triple negative breast cancer? | Lancet Reg Health Eur;40: 100896, 2024 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Into the twilight zone - should ER-low breast cancer be treated as triple negative breast cancer?

Jernström, Helena; Rydén, Lisa.

Affiliation

Jernström H; Department of Clinical Sciences Lund, Oncology, Lund University, Lund, Sweden.
Rydén L; Lund University Cancer Centre (LUCC) and Skåne University Hospital Comprehensive Cancer Center (SUHCC), Sweden.

Lancet Reg Health Eur ; 40: 100896, 2024 May.

Article in En | MEDLINE | ID: mdl-38590941

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Lancet Reg Health Eur Year: 2024 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Lancet Reg Health Eur Year: 2024 Document type: Article Affiliation country: Country of publication: